Cutler Group LP Cin Cor Pharma, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Cin Cor Pharma, Inc. stock. As of the latest transaction made, Cutler Group LP holds 15,000 shares of CINC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CINC
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About CinCor Pharma, Inc.
- Ticker CINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,764,300
- Description
- CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...